Back to search

Article

Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: A retrospective study

2022-05-26

Abstract excerpt

<h4>Background: </h4> Immune checkpoint inhibitors (ICIs) change the prognosis of many cancer patients. With the increasing use of ICIs, immune-related adverse events (irAEs) are occurring, including acute kidney injury (AKI). This study aimed to assess the incidence of ICI-induced AKI and its risk factors and impact on mortality. Method Patients treated with ICIs at the First Medical Center of the Chinese PLA Ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
01f1561c-852d-5823-8efe-f96eaa240297
DOI
10.21203/rs.3.rs-1631843/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: A retrospective studyDOI 10.21203/rs.3.rs-1631843/v2
Immune Checkpoint Inhibitors in Patients with Cancer and Chronic Kidney Disease: A Systematic Review and Meta-AnalysisSemantic proximity
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohortSemantic proximity
The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort studySemantic proximity
Incidence, Risk Factors, and Short-Term Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Selected Hospitals in Southern Ethiopia: A Prospective Cohort StudySemantic proximity
Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in PolandSemantic proximity
Acute Kidney Injuries in different stages of COVID-19: An analysis on patients without prior kidney diseaseSemantic proximity
Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint inhibitors based on serum cytokine levelsSemantic proximity
Soluble and cell-based markers of immune checkpoint inhibitor associated nephritisSemantic proximity
Risk Assessment for Anti-Infectives-Related Acute Kidney Injury Using the Japanese Adverse Drug Event Report DatabaseSemantic proximity
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohort.Semantic proximity
Adverse Renal Effects of Anticancer Immunotherapy: A ReviewSemantic proximity
Two Phenotypes of Acute Kidney Injury Among Patients with COVID-19: A Multicenter Study from Wuhan, ChinaSemantic proximity
Select a neighboring publication to make it the new centre.